Zobrazeno 1 - 10
of 160
pro vyhledávání: '"G A, Markova"'
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 63-70 (2024)
Objective: to evaluate differences in the expression of genes associated with β-oxidation and de novo synthesis of fatty acids (FAs) in the blood of patients with the late stage of knee osteoarthritis (OA) before total knee arthroplasty (TA) dependi
Externí odkaz:
https://doaj.org/article/91e6009f6a584c099909a135e36e1bcd
Publikováno v:
Современная ревматология, Vol 18, Iss 1, Pp 21-27 (2024)
Objective: to investigate the relationship between the expression of genes mediating cellular energy production and the development of chronic postoperative pain (CPP) after total knee arthroplasty (TKA) in patients with osteoarthritis (OA).Material
Externí odkaz:
https://doaj.org/article/4ec4d52833d64d3ca57a2e30dd18a467
Publikováno v:
Современная ревматология, Vol 16, Iss 5, Pp 22-27 (2022)
The effectiveness of personalized therapy for rheumatoid arthritis (RA) is associated with the correct choice of the drug and the ability to predict its effect before starting the treatment.Objective: to study in patients with RA the relationship bet
Externí odkaz:
https://doaj.org/article/bb2a7d79d5cf4afe9b357f860b067bd1
Autor:
E. V. Chetina, K. E. Glemba, G. A. Markova, E. A. Naryshkin, E. A. Taskina, M. A. Makarov, A. M. Lila
Publikováno v:
Современная ревматология, Vol 16, Iss 3, Pp 42-49 (2022)
About 10–40% of patients with osteoarthritis (OA) are not satisfied with the results of total arthroplasty (TA) of large joints. At the same time, the most common complication associated with the ineffectiveness of TA is postoperative pain (PP).Obj
Externí odkaz:
https://doaj.org/article/5e5c12fa5e8b4acf9c9ed7f0fdf75bf5
Publikováno v:
Современная ревматология, Vol 16, Iss 1, Pp 46-51 (2022)
Objective: to search for an association between basal expression of the AMP-activated protein kinase (adenosine monophosphate-activated protein kinase, AMPK) gene in the blood of patients with rheumatoid arthritis (RA) and disease activity, as well a
Externí odkaz:
https://doaj.org/article/f1a8e30906794c20891029aab43e7675
Publikováno v:
Современная ревматология, Vol 17, Iss 1 (2023)
Objective: to evaluate the significance of clinical indicators, expression of pain syndrome genes cathepsin S and pro-inflammatory cytokines in peripheral blood for predicting the development of postoperative pain (POP) in patients with hip osteoarth
Externí odkaz:
https://doaj.org/article/3aa61f19a640443fb8151b18e8e63240
Publikováno v:
Современная ревматология, Vol 15, Iss 5, Pp 12-17 (2021)
Objective: to evaluate the expression of interferon-stimulated genes (ISG) – interferon (IFN) signature – in patients with rheumatoid arthritis (RA) and its dynamics during anti-B-cell therapy.Patients and methods.We examined 20 patients with RA
Externí odkaz:
https://doaj.org/article/c1932dbbb9394b34b393a71c1082685e
Publikováno v:
Современная ревматология, Vol 15, Iss 4, Pp 7-12 (2021)
Osteoarthritis (OA) is the most common disease of the elderly, which is accompanied by pain and damages all tissues of the joint. OA is associated with progressive loss of articular cartilage, sclerotic changes in the subchondral bone and the formati
Externí odkaz:
https://doaj.org/article/85cacb19bac14127a34c215ec7a75813
Publikováno v:
Современная ревматология, Vol 15, Iss 3, Pp 20-26 (2021)
Background. Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology, characterized by erosive arthritis (synovitis) and systemic inflammation. Janus kinase (JAK) inhibitors (JAKi) are small molecules that block major signal pathways of
Externí odkaz:
https://doaj.org/article/9e4acd81183a43a189e2453aed94e12b
Autor:
A. S. Avdeeva, E. V. Tchetina, M. V. Cherkasova, G. A. Markova, A. S. Artyuhov, E. B. Dashinimaev, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 6, Pp 673-677 (2021)
Objective. To assess the expression of interferon-stimulated genes in patients with rheumatoid arthritis (RA).Material and methods. Twenty patients with RA were examined. All patients received methotrexate therapy at a stable dose (Me 15 [10-17.5] mg
Externí odkaz:
https://doaj.org/article/5b5dd1c9406846bab1d09c5abe31e3d5